As the spread of COVID-19 subsides, blood supply in Taiwan has fallen to critically low levels. On Nov. 25, the International Research-Based Pharmaceutical Manufacturers Association (IRPMA), comprised of multinational pharmaceutical manufacturers, mobilized 48 member corporations to jointly run a blood drive with the Taipei Blood Center. In the spirit of Thanksgiving, the association demonstrated its motto of “IRPMA Can Help” and its desire to give back to society and lend aid to those in need. Two blood trucks were dispatched, collecting 300 units of blood.

IRPMA President Chen Jung-hua participated in the blood drive. “This year, everyone has suffered due to the pandemic, especially the frontline health workers. IRPMA once again collaborated with TBSF to express our gratitude through action, and hope that the blood drive will become a welcomed tradition in rallying our partners, and further the spirit that “IRPMA Can Help”, President Chen said.

IRPMA Public Affairs Committee Co-Chairman Chang Po-sheng and Li Ming-fa noted that “Domestic spread has stabilized, thanks to gradually rising vaccination rates and adherence to public health protocols. Furthermore, global pharma companies have made great strides towards launching COVID-19 oral drugs, bringing more treatment options. IRPMA has also continued its dedication to the development of new drugs to improve health.” The theme of the blood drive, themed as “Thankful to have you, we shall pay it forward with care,” is also a nod to healthcare workers at the frontlines of the pandemic who have been entrusted with the tremendous responsibility of keeping people safe. IRPMA also expressed gratitude to all the pharmaceutical companies for their efforts in innovative research and development aimed at helping people return to normal daily lives as soon as possible.

[2021-11-25/ETtoday]